Enliven Therapeutics, Inc. (ELVN)

CIK 1672619 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Enliven Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 202610-Q0001193125-26-449870
Nov 5, 20268-K0001193125-26-449819
Nov 3, 202640001536368-26-000008
Oct 27, 2026SCHEDULE 13G/A0002012383-26-003776
Oct 21, 202640001882764-26-000009
Oct 21, 202640001701247-26-000014
Oct 19, 20261440001974158-26-000109
Oct 16, 202640001266163-26-000003
Oct 16, 202630001266163-26-000002
Oct 14, 20268-K0001193125-26-421761
Oct 5, 202640001533228-26-000009
Oct 1, 20261440001950047-26-009907
Sep 21, 202640001882764-26-000008
Sep 21, 202640001701247-26-000013
Sep 17, 20261440001974158-26-000103
Sep 4, 20261440001959173-26-006749
Aug 19, 202640001701247-26-000012
Aug 19, 202640001882764-26-000007
Aug 6, 2026SCHEDULE 13G/A0000315066-26-001988
Aug 6, 202640001865125-26-000004
Aug 5, 20268-K0001193125-26-335101
Aug 5, 202610-Q0001193125-26-335155
Aug 4, 20261440001974158-26-000095
Jul 21, 202640001701247-26-000011
Jul 21, 202640001882764-26-000006